Hopman Mark's Form 4 filing
Beta Bionics, Inc. (BBNX) · filed Sep 8, 2025
- Accession no.
- 0001415889-25-023899
- Filed
- Sep 8, 2025
- Trade date
- Sep 4-5, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $370.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hopman MarkCIK 0002048497 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Common Stock | MOption exerciseAcquired | +656 | $5.10 | +$3,345.6 | 33,940 | Direct | |
| Sep 4, 2025 | Common Stock | MOption exerciseAcquired | +4,093 | $5.10 | +$20,874.3 | 38,033 | Direct | |
| Sep 4, 2025 | Common Stock | SSaleDisposed | −6,818 | $19.97 | −$136,155.46 | 31,215 | Direct | |
| Sep 5, 2025 | Common Stock | MOption exerciseAcquired | +11,411 | $5.10 | +$58,196.1 | 42,626 | Direct | |
| Sep 5, 2025 | Common Stock | SSaleDisposed | −11,411 | $20.56 | −$234,610.16 | 31,215 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Common Stock | MOption exerciseDisposed | −656 | $0.00 | $0 | 66,428 | Direct | |
| Sep 4, 2025 | Common Stock | MOption exerciseDisposed | −4,093 | $0.00 | $0 | 33,136 | Direct | |
| Sep 5, 2025 | Common Stock | MOption exerciseDisposed | −11,411 | $0.00 | $0 | 21,725 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.